• Appointed to investigate allegations of bribery and corruption in
an international pharma company.
Fortune spoke with 25 - year pharmaceutical vet Ramona Sequeira, president of Takeda's U.S. business unit since 2015, on the challenges of adapting
an international pharma company to the U.S. healthcare and reimbursement system and the firm's America - centric business plans.
Not exact matches
Health Canada said that four
companies have authorization to sell epinephrine auto - injectors — Kaleo
Pharma, Taro Pharmaceutical Industries Ltd, Valeant Pharmaceuticals
International Inc and Lincoln Medical Ltd — but none are currently marketing them in the country.
The five
companies Ohio sued were Purdue
Pharma LP, Johnson & Johnson's Janssen Pharmaceuticals Inc unit, a unit of Endo
International Plc, Teva Pharmaceutical Industries Ltd's Cephalon unit and Allergan Plc, DeWine said during a press conference in Columbus livestreamed online.
«As a global
company on the forefront of healthcare change, Astellas is proud to once again be a part of bringing
international rugby back to Chicago, a great sporting city and the headquarters for Astellas in the Americas,» said James Robinson, president, Astellas
Pharma US.
We are in touch with the Austrian Academy of Sciences, the Federal Ministry of Education and Research, various public and private institutions and agencies, various Viennese universities, numerous biotech and
pharma companies, biotech consultancies, and
international student clubs that share Club Biotech's visions and goals.
In addition, «what attracts people to biotech rather than
pharma is that decision lines are much shorter; there is an easy access to everyone in the
company,» comments Nicolas Hollanders, a recruitment consultant specialising in biotechnology at Egon Zehnder
International in Brussels.
With more than 1,200
international actors from 35 + countries, such as big
pharma, emerging and small biotech, diagnostics
companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia - industry collaborations and early - stage innovations in the field of Life Sciences.
Massimo holds a Ph.D. from the University of Milan, where he graduated with honors, and currently serves on the boards of various
companies such as Bioakos
Pharma, Arriani
International and Ariad Pharmaceuticals.